References and Notes
1
Sauer J.
Comprehensive Heterocyclic Chemistry II
Vol. 6:
Pergamon;
London:
1996.
p.901-965
2
Boger DL.
Weinreb SM.
Hetero Diels-Alder Methodology in Organic Synthesis
Academic Press;
San Diego, CA:
1987.
3 Schirmer U, Wierzer B, Meyer N, Neugebauer FA, and Fischer H. inventors; Ger. Patent, 3508214.
; Chem. Abstr. 1987, 106, 45718
4a
Chavez DE.
Hiskey MA.
J. Energ. Mat.
1999,
174:
357
4b
Chavez DE.
Hiskey MA.
Naud DL.
Propellants, Explos., Pyrotech.
2004,
29:
209
5a
Boger DL.
Tetrahedron
1983,
39:
2869
5b
Boger DL.
Chem. Rev.
1986,
86:
781
5c
Yang X.-G.
Seitz G.
Arch. Pharm. (Weinheim)
1992,
325:
559
5d
Boger DL.
Schaum RP.
Garbaccio RM.
J. Org. Chem.
1998,
63:
6329
5e
Benson SC.
Lee L.
Yang L.
Snyder JK.
Tetrahedron
2000,
56:
1165
5f
Hamasaki A.
Ducray R.
Boger DL.
J. Org. Chem.
2006,
71:
185
6a
Boger DL.
Coleman RS.
Panek JS.
Yohannes D.
J. Org. Chem.
1984,
49:
4405
6b
Boger DL.
Panek JS.
Duff SR.
J. Am. Chem. Soc.
1985,
107:
5745
6c
Boger DL.
Sakya SM.
J. Org. Chem.
1988,
53:
1415
6d
Yang X.-G.
Seitz G.
Chem.-Ztg.
1991,
115:
367
6e
Boger DL.
Zhang M.
J. Am. Chem. Soc.
1991,
113:
4230
6f
Benson SC.
Lee L.
Snyder JK.
Tetrahedron Lett.
1996,
37:
5061
6g
Sauer J.
Heldmann DK.
Tetrahedron
1998,
54:
4297
6h
Girardot M.
Nomak R.
Snyder JK.
J. Org. Chem.
1998,
63:
10063
6i
Wan Z.-K.
Woo GHC.
Snyder JK.
Tetrahedron
2001,
57:
5497
6j
Hamasaki A.
Zimpleman JM.
Hwang I.
Boger DL.
J. Am. Chem. Soc.
2005,
127:
10767 ; and references cited therein
7
Seitz G.
Yang X.-G.
Arch. Pharm. (Weinheim)
1991,
324:
803
8a
Sakya SM.
Groskopf KK.
Boger DL.
Tetrahedron Lett.
1997,
38:
3805
8b
Novak Z.
Bostai B.
Csekei M.
Lorincz K.
Kotschy A.
Heterocycles
2003,
60:
2653
8c
Huynh MHV.
Hiskey MA.
Chavez DE.
Naud DL.
Gilardi RD.
J. Am. Chem. Soc.
2005,
127:
12537 ; and references cited therein
9
Mangia A.
Bartesi F.
Amendola U.
J. Heterocycl. Chem.
1977,
14:
587
10
Novak Z.
Kotschy A.
Org. Lett.
2003,
5:
3495
11a
Miyaura N.
Yamada K.
Suzuki A.
Tetrahedron Lett.
1979,
20:
3437
11b
Stille JK.
Angew. Chem. Int. Ed.
1986,
25:
508
For recent reviews on Pd-catalyzed cross-coupling reactions, see:
11c
Littke AF.
Fu GC.
Angew. Chem. Int. Ed.
2002,
41:
4176
11d
Nicolaou KC.
Bulger PG.
Sarlah D.
Angew. Chem. Int. Ed.
2005,
44:
4442
11e For a recent review on the applications of the Suzuki-Miyaura cross-coupling reactions, see: Kotha S.
Lahiri K.
Kashinath D.
Tetrahedron
2002,
58:
9633
11f For a recent review on the mechanisms of the Stille cross-coupling reactions, see: Espinet P.
Echavarren AM.
Angew. Chem. Int. Ed.
2004,
43:
4704
12
Sandström J.
Acta Chem. Scand.
1961,
15:
1575
13a
Liebeskind LS.
Srogl J.
J. Am. Chem. Soc.
2000,
122:
11260
13b
Savarin C.
Srogl J.
Liebeskind LS.
Org. Lett.
2001,
3:
91
13c
Savarin C.
Liebeskind LS.
Org. Lett.
2001,
3:
2149
13d
Kusturin CL.
Liebeskind LS.
Neumann WL.
Org. Lett.
2002,
4:
983
14a
Liebeskind LS.
Srogl J.
Org. Lett.
2002,
4:
979
14b
Alphonse F.-A.
Suzenet F.
Keromnes A.
Lebret B.
Guillaumet G.
Synlett
2002,
447
15a
Egi M.
Liebeskind LS.
Org. Lett.
2003,
5:
801
15b
Alphonse F.-A.
Suzenet F.
Keromnes A.
Lebret B.
Guillaumet G.
Org. Lett.
2003,
5:
803
16a
Kusturin C.
Liebeskind LS.
Rahman H.
Sample K.
Schweitzer B.
Srogl J.
Neumann WL.
Org. Lett.
2003,
5:
4349
16b
Oumouch S.
Bourotte M.
Schmitt M.
Bourguignon J.-J.
Synthesis
2005,
25
16c
Richardson C.
Rewcastle GW.
Hoyer D.
Denny WA.
J. Org. Chem.
2005,
70:
7436
16d Leconte, N.; Pellegatti, L.; Xavier, N.; Tatibouët, A.; Suzenet, F.; Rollin, P.; Guillaumet, G. Synthesis, accepted.
17 (17) 3-Methylthio-6-(morpholin-4-yl)-1,2,4,5-tetrazine (1): To a suspension of 3,6-bis(methylthio)-1,2,4,5-tetrazine (1.08 g, 6.2 mmol) in EtOH (20 mL) at 25 °C, morpholine (660 µL, 7.5 mmol) was added. After the mixture was refluxed for 15 h, it was allowed to cool to r.t. and the solvent was removed under reduced pressure. The residue was purified by chromatography on silica gel (cyclohexane-EtOAc = 95:5 to 8:2). 3-Methylthiotetrazine 1 (1.24 g, 94%) was obtained as a red solid; mp 131-132 °C. MS (Ionspray®): m/z = 214 [M + H]+. 1H NMR (250 MHz, CDCl3): δ = 3.94 (dt, J = 1.0, 4.8 Hz, 4 H), 3.84 (dt, J = 1.0, 4.8 Hz, 4 H), 2.67 (s, 3 H). 13C NMR (62.5 MHz, CDCl3): δ = 166.6 (C), 160.5 (C), 66.5 (CH2), 43.9 (CH2), 13.7 (CH3). IR: 2965, 2908, 1524, 1441, 1267, 1113, 920, 847, 791 cm-1. HRMS: m/z [M+·] calcd for C7H11N5OS: 213.0684; found: 213.0687.
18
Palladium-Catalyzed Cross-Coupling Reaction of Compound 1 with Boronic Acids 2a-i; General Procedure: 3-Methylthio-6-(morpholin-4-yl)-1,2,4,5-tetrazine (1; 100 mg, 0.5 mmol), boronic acid (1.1 mmol) and CuTC (197 mg, 1.1 mmol) were dissolved in anhyd DME (5 mL) in a sealed reaction vessel under argon. After the mixture was degassed, Pd(PPh3)4 (27 mg, 0.025 mmol) was added and the reaction mixture was stirred under microwave irradiation at 200 °C (14-16 bars) for 2 h. The reaction mixture was then allowed to cool to r.t., poured into sat. aq Na2CO3 and extracted with CH2Cl2. The organic phases were collected, dried over MgSO4 and the solvent was removed under reduced pressure. Desired compounds were purified by chromatography on silica gel (PE-EtOAc = 95:5 to 7:3).
3-(Morpholin-4-yl)-6-(4-methoxyphenyl)-1,2,4,5-tetrazine (
3a): 4-Methoxyphenylboronic acid (2a; yield: 71%) and 1-methoxy-4-tributylstannylbenzene (4a; yield: 49%) were used as the boronic acid and the organostannane derivatives, respectively; red solid; mp 176-178 °C. MS (Ionspray®): m/z = 274 [M + H]+. 1H NMR (250 MHz, CDCl3): δ = 8.34 (d, J = 9.0 Hz, 2 H), 7.05 (d, J = 9.0 Hz, 2 H), 4.04 (t, J = 4.5 Hz, 4 H), 3.89 (s, 3 H), 3.87 (t, J = 4.5 Hz, 4 H). 13C NMR (62.5 MHz, CDCl3): δ = 162.0 (C), 160.6 (C), 159.5 (C), 128.0 (CH), 125.3 (C), 114.6 (CH), 66.6 (CH2), 55.6 (CH3), 43.9 (CH2). IR: 2917, 1607, 1512, 1438, 1244, 1116, 1034, 936, 837 cm-1. Anal. Calcd for C13H15N6O2
(273): C, 57.13; H, 5.53; N, 25.63. Found: C, 57.34; H, 5.52; N, 24.48.
3-(Morpholin-4-yl)-6-(3-methoxyphenyl)-1,2,4,5-tetrazine (
3b): 3-Methoxyphenylboronic acid (2b) was used as the boronic acid derivative; yield: 67%; red solid; mp 140-142 °C. MS (Ionspray®): m/z = 274 [M + H]+. 1H NMR (250 MHz, CDCl3): δ = 7.99 (dt, J = 1.0, 8.0 Hz, 1 H), 7.93 (dd, J = 1.0, 2.6 Hz, 1 H), 7.43 (t, J = 8.0 Hz, 1 H), 7.05 (ddd, J = 1.0, 2.6, 8.0 Hz, 1 H), 4.05 (t, J = 4.5 Hz, 4 H), 3.89 (s, 3 H), 3.87 (t, J = 4.5 Hz, 4 H). 13C NMR (62.5 MHz, CDCl3): δ = 160.5 (C), 160.2 (C), 159.3 (C), 134.0 (C), 130.1 (CH), 118.8 (CH), 117.4 (CH), 110.7 (CH), 66.5 (CH2), 55.5 (CH3), 43.8 (CH2). IR: 2927, 2857, 1598, 1522, 1448, 1262, 1229, 1119, 963, 786 cm-1. HRMS: m/z [M+·] calcd for C13H15N5O2: 273.1226; found: 273.1220.
3-(Morpholin-4-yl)-6-(3-methylphenyl)-1,2,4,5-tetrazine (
3c): 3-Methylphenylboronic acid (2c) was used as the boronic acid derivative; yield 58%; red solid; mp 127-129 °C. MS (Ionspray®): m/z = 258.5 [M + H]+. 1H NMR (250 MHz, CDCl3): δ = 8.22 (s, 1 H), 8.20 (d, J = 7.8 Hz, 1 H), 7.42 (t, J = 7.8 Hz, 1 H), 7.33 (d, J = 7.8 Hz, 1 H), 4.06 (t, J = 4.7 Hz, 4 H), 3.88 (t, J = 4.7 Hz, 4 H), 2.46 (s, 3 H). 13C NMR (62.5 MHz, CDCl3): δ = 160.6 (C), 159.7 (C), 139.9 (C), 132.6 (C), 131.6 (CH), 129.1 (CH), 127.1 (CH), 123.6 (CH), 66.6 (CH2), 43.9 (CH2), 21.7 (CH3). IR: 2965, 2860, 2362, 2338, 1521, 1451, 1252, 1116, 941, 784 cm-1. HRMS: m/z [M+·] calcd for C13H15N5O: 257.1277; found: 257.1288.
3-(Morpholin-4-yl)-6-(3-acetylphenyl)-1,2,4,5-tetrazine (
3d): 3-Acetylphenylboronic acid (2d) was used as the boronic acid derivative; yield: 56%; red solid; mp 174-176 °C. MS (Ionspray®): m/z = 286 [M + H]+. 1H NMR (250 MHz, CDCl3): δ = 8.98 (s, 1 H), 8.60 (d, J = 7.9 Hz, 1 H), 8.12 (d, J = 7.9 Hz, 1 H), 7.65 (t, J = 7.9 Hz, 1 H), 4.09 (t, J = 4.4 Hz, 4 H), 3.89 (t, J = 4.4 Hz, 4 H), 2.70 (s, 3 H). 13C NMR (62.5 MHz, CDCl3): δ = 197.7 (C), 160.5 (C), 158.7 (C), 137.9 (C), 133.2 (C), 130.5 (CH), 130.1 (CH), 129.5 (CH), 126.4 (CH), 66.5 (CH2), 43.8 (CH2), 26.9 (CH3). IR: 2981, 2906, 2359, 2340, 1692, 1536, 1262, 1111, 967, 946 cm-1. HRMS: m/z [M+·] calcd for C14H15N5O2: 285.1226; found: 285.1213.
3-(Morpholin-4-yl)-6-(4-acetylphenyl)-1,2,4,5-tetrazine (
3e): 4-Acetylphenylboronic acid(2e) was used as the boronic acid derivative; yield: 54%; red solid; mp 194-197 °C. MS (Ionspray®): m/z = 286 [M + H]+. 1H NMR (250 MHz, CDCl3): δ = 8.49 (d, J = 8.8 Hz, 2 H), 8.11 (d, J = 8.8 Hz, 2 H), 4.09 (t, J = 4.6 Hz, 4 H), 3.89 (t, J = 4.6 Hz, 4 H), 2.41 (s, 3 H). 13C NMR (62.5 MHz, CDCl3): δ = 197.7 (C), 160.2 (C), 158.7 (C), 138.6 (C), 136.9 (C), 129.1 (CH), 126.4 (CH), 66.6 (CH2), 43.9 (CH2), 26.9 (CH3). IR: 2975, 2874, 2324, 1676, 1536, 1269, 1114, 943, 849 cm-1. HRMS: m/z [M+·] calcd for C14H15N5O2: 285.1226; found: 285.1216.
3-(Morpholin-4-yl)-6-(3-cyanophenyl)-1,2,4,5-tetrazine (
3f): 3-Cyanophenylboronic acid (2f) was used as the boronic acid derivative; yield: 28%; red solid; mp 197-198 °C. MS (Ionspray®): m/z = 269 [M + H]+. 1H NMR (250 MHz, CDCl3): δ = 8.71 (dt, J = 0.5, 1.5 Hz, 1 H), 8.63 (dt, J = 1.5, 8.0 Hz, 1 H), 7.79 (dt, J = 1.5, 8.0 Hz, 1 H), 7.65 (dt, J = 0.5, 8.0 Hz, 1 H), 4.09 (t, J = 4.7 Hz, 4 H), 3.89 (t, J = 4.7 Hz, 4 H). 13C NMR (62.5 MHz, CDCl3): δ = 160.4 (C), 157.8 (C), 134.1 (C), 133.8 (CH), 130.1 (CH), 130.0 (CH), 129.8 (CH), 118.5 (C), 113.5 (C), 66.5 (CH2), 43.9 (CH2). IR: 2872, 2235, 1536, 1446, 1255, 1117, 1034, 966 cm-1. HRMS: m/z [M+·] calcd for C13H12N6O: 268.1073; found: 268.1079.
3-(Morpholin-4-yl)-6-(3-trifluoromethylphenyl)-1,2,4,5-tetrazine (
3g): 3-Trifluoromethylphenylboronic acid (2g) was used as the boronic acid derivative; yield: 31%; red solid; mp 144 °C. MS (Ionspray®): m/z = 311.5 [M + H]+. 1H NMR (250 MHz, CDCl3): δ = 8.69 (s, 1 H), 8.58 (d, J = 7.8 Hz, 1 H), 7.76 (d, J = 7.8 Hz, 1 H), 7.66 (t, J = 7.8 Hz, 1 H), 4.08 (t, J = 4.5 Hz, 4 H), 3.89 (t, J = 4.5 Hz, 4 H). 13C NMR (62.5 MHz, CDCl3): δ = 160.5 (C), 158.4 (C), 133.6 (C), 131.6 (2
J
C-F = 33 Hz, C), 129.7 (CH), 129.3 (CH), 127.3 (3
J
C-F = 4 Hz, CH), 124.1 (1
J
C-F = 271 Hz, C), 123.2 (3
J
C-F = 4 Hz, CH), 66.5 (CH2), 43.9 (CH2). IR: 2917, 2850, 1530, 1446, 1302, 1268, 1166, 1120, 1066, 1034, 963, 945, 695 cm-1. HRMS: m/z [M+·] calcd for C13H12N5OF3: 311.0994; found: 311.0991.
3-(Morpholin-4-yl)-6-(3-bromophenyl)-1,2,4,5-tetrazine (
3h): 3-Bromophenylboronic acid (2h) was used as the boronic acid derivative; yield: 42%; red solid; mp 141-142 °C. 1H NMR (250 MHz, CDCl3): δ = 8.56 (t, J = 1.5 Hz, 1 H), 8.33 (ddd, J = 1.0, 1.5, 8.0 Hz, 1 H), 7.64 (ddd, J = 1.0, 1.5, 8.0 Hz, 1 H), 7.40 (t, J = 8.0 Hz, 1 H), 4.07 (t, J = 4.4 Hz, 4 H), 3.88 (t, J = 4.4 Hz, 4 H). 13C NMR (62.5 MHz, CDCl3): δ = 160.5 (C), 158.4 (C), 134.8 (C), 133.7 (CH), 130.6 (CH), 129.4 (CH), 124.8 (CH), 123.4 (C), 66.6 (CH2), 43.9 (CH2). IR: 2361, 2337, 1530, 1447, 1254, 1123, 1031, 944, 780, 733 cm-1. HRMS: m/z [M+·] calcd for C12H12N5O79Br: 321.0225; found: 321.0211.
3-(Morpholin-4-yl)-6-(naphtalen-2-yl)-1,2,4,5-tetrazine (
3i): Naphthalen-2-ylboronic acid (2i) was used as boronic acid derivative; yield: 60%; red solid; mp 172-173 °C. MS (Ionspray®): m/z = 294 [M + H]+. 1H NMR (250 MHz, CDCl3): δ = 8.93 (s, 1 H), 8.48 (dd, J = 1.8, 8.5 Hz, 1 H), 7.99 (d, J = 8.5 Hz, 2 H), 7.89 (t, J = 5.0 Hz, 1 H), 7.54 (m, 2 H), 4.08 (t, J = 4.5 Hz, 4 H), 3.89 (t, J = 4.5 Hz, 4 H). 13C NMR (62.5 MHz, CDCl3): δ = 160.5 (C), 159.7 (C), 134.7 (C), 133.5 (C), 130.0 (C), 129.2 (CH), 129.0 (CH), 128.0 (CH), 127.4 (CH), 126.8 (CH), 126.5 (CH), 123.3 (CH), 66.6 (CH2), 43.9 (CH2). IR: 2960, 2869, 2359, 1522, 1451, 1336, 1262, 1119, 953 cm-1. Anal. Calcd for C16H15N5O(293): C, 65.52; H, 5.15; N, 23.88. Found: C, 65.64; H, 5.07; N, 23.26.
19
Cross-Coupling Reaction Followed by an Oxidative Treatment (Compounds 3g-j): Same procedure as in ref. 18 was used with an extra oxidative step, described as follows. The crude product was dissolved in CH2Cl2. After the temperature was adjusted to 5 °C with an ice bath, MCPBA (81 mg, 0.47 mmol) was added and the mixture was stirred for 30 min at 5 °C. The reaction was then hydrolyzed with sat. aq NaHCO3 and extracted with CH2Cl2. The organic phases were collected, dried over MgSO4 and the solvent was removed under reduced pressure. Desired compounds were purified by chromatography on silica gel (PE-EtOAc: 95:5 to 7:3).
20
Palladium-Catalyzed Cross-Coupling Reaction of Compound 1 with Organostannanes 4a-d; General Procedure: Same procedure as in ref. 18 was used except that the reaction was carried out with organotin derivatives.
3-(Morpholin-4-yl)-6-[(
E
)-styryl]-1,2,4,5-tetrazine (
3j): 3-[(E)-2-Phenylethenyl]tributyltin (4b) was used as the organostannane derivative; yield: 34%; red solid; mp 126 °C. MS (Ionspray®): m/z = 270 [M + H]+. 1H NMR (250 MHz, CDCl3): δ = 7.96 (d, J = 16.3 Hz, 1 H), 7.62 (dd, J = 1.5, 8.3 Hz, 2 H), 7.41 (m, 3 H), 7.35 (d, J = 16.3 Hz, 1 H), 4.03 (t, J = 4.5 Hz, 4 H), 3.86 (t, J = 4.5 Hz, 4 H). 13C NMR (62.5 MHz, CDCl3): δ = 160.1 (C), 160.0 (C), 136.0 (C), 135.7 (CH), 129.3 (CH), 129.0 (CH), 127.6 (CH), 121.1 (CH), 66.6 (CH2), 43.8 (CH2). IR: 2956, 2863, 1637, 1521, 1450, 1341, 1254, 1119, 1056, 949, 848, 751, 693 cm-1. HRMS: m/z [M+·] calcd for C14H15N5O: 269.1277; found: 269.1274.
3-(Morpholin-4-yl)-6-(thien-2-yl)-1,2,4,5-tetrazine (
3k): 2-Tributylstannylthiophene (4c) was used as the organostannane derivative; yield: 42%; red solid; mp 187-191 °C. MS (Ionspray®): m/z = 250 [M + H]+. 1H NMR (250 MHz, CDCl3): δ = 8.00 (dd, J = 1.0, 3.8 Hz, 1 H), 7.50 (dd, J = 1.0, 5.0 Hz, 1 H), 7.19 (dd, J = 3.8, 5.0 Hz, 1 H), 4.03 (t, J = 4.4 Hz, 4 H), 3.87 (t, J = 4.4 Hz, 4 H). 13C NMR (62.5 MHz, CDCl3): δ = 160.4 (C), 157.8 (C), 136.7 (C), 129.2 (CH), 128.5 (CH), 127.6 (CH), 66.6 (CH2), 43.9 (CH2). IR: 2965, 2907, 2866, 2362, 2341, 1529, 1433, 1259, 1112, 941, 718 cm-1. HRMS: m/z [M+·] calcd for C10H11N5OS: 249.0684; found: 249.0693.
3-(Morpholin-4-yl)-6-(pyridin-4-yl)-1,2,4,5-tetrazine (
3l): 4-Tributylstannylpyridine (4d) was used as the organostannane derivative; yield: 30%; red solid; mp 198-199 °C. MS (Ionspray®): m/z = 245.5 [M + H]+. 1H NMR (250 MHz, CDCl3): δ = 8.81 (br s, 2 H), 8.26 (d, J = 4.1 Hz, 2 H), 4.11 (t, J = 4.7 Hz, 4 H), 3.89 (t, J = 4.7 Hz, 4 H). 13C NMR (62.5 MHz, CDCl3): δ = 160.4 (C), 157.9 (C), 150.9 (C), 140.1 (CH), 66.6 (CH2), 43.9 (CH2); C9 was not observed. IR: 2989, 2902, 1593, 1520, 1443, 1340, 1250, 1117, 1037, 966, 942, 846 cm-1. Anal. Calcd for C11H12N6O(244): C, 54.09; H, 4.95; N, 34.41. Found: C, 54.41; H, 4.93; N, 34.55.
21 For preparation of compound 4a, see: Morita Y.
Kashiwagi A.
Nakasuji K.
J. Org. Chem.
1997,
62:
7464
22 For preparation of compound 4b, see ref. 15b.
23 For preparation of compound 4d, see: Peters D.
Hörnfeldt A.-B.
Gronowitz S.
J. Heterocycl. Chem.
1990,
27:
2165
24 The same experimental procedure as described in ref. 18 was used, except that the reaction was carried out in a 10 mL round-bottomed flask and stirred in refluxing DME for 48 h.
25 In refluxing DME after 48 hours, only traces of the cross-coupling product 6 were observed.
3-Methoxy-6-(4-methoxyphenyl)-1,2,4,5-tetrazine (
6): 3-Methylthio-6-methoxy-1,2,4,5-tetrazine (5; 129 mg, 0.8 mmol), 4-methoxyphenylboronic acid (2a; 277 mg, 1.8 mmol) and CuTC (342 mg, 1.8 mmol) were dissolved in anhyd DME (6 mL) in a sealed reaction vessel under argon. After the mixture was degassed, Pd(PPh3)4 (47 mg, 0.04 mmol) was added and the reaction mixture was stirred under microwave irradiation at 200 °C for 2 h. The reaction mixture was then allowed to cool to r.t., poured into sat. Na2CO3 and extracted with CH2Cl2. The organic phases were collected, dried over MgSO4 and the solvent was removed under reduced pressure. Purification by chromatography on silica gel (PE-EtOAc: 1:0 to 9:1) afforded compound 7 (22 mg, 12%) as a red solid; mp 119-120 °C. MS (Ionspray®): m/z = 219 [M + H]+. 1H NMR (250 MHz, CDCl3): δ = 8.46 (d, J = 9.0 Hz, 2 H), 7.07 (d, J = 9.0 Hz, 2 H), 4.34 (s, 3 H), 3.91 (s, 3 H). 13C NMR (62.5 MHz, CDCl3): δ = 166.8 (C), 163.1 (C), 162.9 (C), 129.3 (CH), 124.3 (C), 114.8 (CH), 56.6 (CH3), 55.6 (CH3). IR: 2923, 2854, 1602, 1488, 1453, 1376, 1249, 1179, 1117, 1041, 940, 848 cm-1. HRMS: m/z [M+·] calcd for C10H10N4O2: 218.0804; found: 218.0797.
